Crane Co T.CR

Primary Symbol: CR Alternate Symbol(s): CXT

Crane Company is a manufacturer of engineered components for mission-critical applications focused on the aerospace, defense, space and process flow industry end markets. Its segments include Aerospace & Electronics, Process Flow Technologies, and Engineered Materials. The Aerospace & Electronics segment supplies critical components and systems, including original equipment and aftermarket parts, primarily for the commercial aerospace, and the military aerospace, defense and space markets. The Process Flow Technologies segment is a provider of engineered fluid handling equipment for critical applications. The Engineered Materials segment manufactures fiberglass-reinforced plastic panels and coils, primarily for use in the manufacturing of recreational vehicles, truck bodies and trailers (Transportation). It also designs and manufacturers multi-stage lubrication pumps and lubrication system components technology for critical aerospace and defense applications.

NYSE:CR - Post by User

Crane Co

Bullboard Posts

Post by CatamaranFundon Feb 26, 2020 12:14pm

129 Views

Post# 30735977

Crew: Analysts report from various reputable sources

Based on 6 ranked analysts offering 12 month price targets for CWEGF in the last 3 months, the average price target is $0.90, with a high estimate of $1.25 and a low estimate of $0.65. So at $0.90 there is a +158.17% Upside. Based on 6 analyst ratings for CWEGF in the last 3 months, the overall rating is Buy.

Buy 50%
Hold 50%
Sell 0%
Company Insider: There was also Public Market Buying on Jan 27/2020 by John Albert Brussa (Director) @ approx. 0.45 to 0.50 per share for a total of
275,000 shares.
Thomson Reuters has a BUY rating from 16 analysts, with
1 -Strong Buy,
8 -Buys,
7- Holds, and
0 -Reduce or Sells
Stock Reports+ for Feb 25, 2020 reveals the 12 month projected Price Target as:
Mean: $0.84
High: $1.25
Low: $0.50
Target vs. current +121.1%
Even Morningstar as of Feb24, 2020 has a Fair Value of $0.66,
Last close 0.35, stating that CR is Undervalued at a 42% Discount
Also TD Securities has a BUY and Target of $1.00 (Juan Jarrah, CFA)

This is definately a time to "know when to Hold em", not when to 'Fold em' so consideration should be given to buying in at these lowers levels.
Discloure: i bought higher and have average down to Cheers to all battered but PATIENT investors

Bullboard Posts

The top 10 Canadian medical stocks